+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

From
From
From
From
From
From
From
From
From
Aptamers Market - Global Forecast 2026-2030 - Product Thumbnail Image

Aptamers Market - Global Forecast 2026-2030

  • Report
  • January 2026
  • 190 Pages
  • Global
From
Pompe Disease Market Report 2025 - Product Thumbnail Image

Pompe Disease Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
14-alpha Demethylase Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

14-alpha Demethylase Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Gene Therapy Market - Global Forecast 2026-2032 - Product Thumbnail Image

Gene Therapy Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 199 Pages
  • Global
From
Androgen Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Androgen Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Oncology Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Oncology Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 187 Pages
  • Global
From
Urothelial Cancer Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Urothelial Cancer Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 196 Pages
  • Global
From
Loading Indicator